LT - P2X3 moduliatoriaus metilo (S)-2-((2-(2,6-difluor-4-(metilkarbamoil)fenil) -7-metilimidazo[1,2-a]piridin-3-il)metil)morfolin-4-karboksilato kristalinės formos
EN - CRYSTALLINE FORMS OF P2X3 MODULATOR METHYL (S)-2-((2-(2,6-DIFLUORO-4-(METHYLCARBAMOYL )PHENYL)-7-METHYLIMIDAZO[1,2-A]PYRIDIN-3-YL)METHYL)MORPHOLINE-4-CARBOXYLATE
Legal status
Patent in force
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
C07D 471/04 |
(2006.01) |
|
|
A61K 31/5377 |
(2006.01) |
|
|
A61P 11/14 |
(2006.01) |
|
|
A61P 13/00 |
(2006.01) |
|
|
A61P 15/00 |
(2006.01) |
|
|
A61P 17/04 |
(2006.01) |
|
|
A61P 29/00 |
(2006.01) |
European patent
| (11) |
Number of the document |
3880678 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
19884611.5 |
|
Date of filing the European patent application |
2019-11-12 |
| (97) |
Date of publication of the European application |
2021-09-22 |
| (45) |
Date of publication and mention of the grant of the patent |
2025-05-07
|
| (46) |
Date of publication of the claims translation |
2025-06-25
|
PCT application
| (86) |
Number |
PCT/IB2019/001199 |
|
Date |
2019-11-12 |
PCT application publication
| (87) |
Number |
WO 2020/099923 |
|
Date |
2020-05-22 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
201862760307 P |
2018-11-13
|
US |
Inventors
| (72) |
GARCEAU, Denis , CA
WENSLOW, Robert M. , CA
PAYZA, Kemal , CA
CHAURET, Nathalie , CA
|
Grantee
| (73) |
GlaxoSmithKline Intellectual Property (No.3)
Limited ,
GSK Medicines Research Centre
Gunnels Wood Road, Stevenage SG1 2NY,
GB
|
Attorney or representative
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Title
| (54) |
P2X3 moduliatoriaus metilo (S)-2-((2-(2,6-difluor-4-(metilkarbamoil)fenil) -7-metilimidazo[1,2-a]piridin-3-il)metil)morfolin-4-karboksilato kristalinės formos |
| |
CRYSTALLINE FORMS OF P2X3 MODULATOR METHYL (S)-2-((2-(2,6-DIFLUORO-4-(METHYLCARBAMOYL )PHENYL)-7-METHYLIMIDAZO[1,2-A]PYRIDIN-3-YL)METHYL)MORPHOLINE-4-CARBOXYLATE |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2025-10-22 |
7 |
162.00
EUR
|
Next renewal fee
|
2026-11-12 |
